Professional Media briefs

Share this article:
Sermo has entered into a strategic partnership with Janssen Global Services to develop mobile and web services allowing physicians to refer a patient for care while ensuring continuity in care. The offering will aim to “close the loop” for all care team members, said Sermo, allowing for greater coordination of care between primary care physicians and specialists, for example.
 
Henry Schein, Inc. launched BioTherapeutics Quarterly, a new journal designed to serve as a quick information source on the prevention, diagnosis and treatment of disease. The journal published in February and will be published again in May, August and November, with an online version in the works for sometime in 2012. Melville, NY-based Henry Schein also publishes the Xchange monthly e-newsletter for healthcare professionals.
 
Wolters Kluwer Pharma Solutions announced an open access publishing option for authors submitting original research articles to the Adis line of 16 pharmacology and pharmacotherapy journals. The journals were previously available only through pay per view or subscription, but researchers will now have access to much of the content, and for existing subscribers, it will be free additional content, said the firm. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?